New Delhi, 19 Jan 2023: The worth of prime promoting cardiac arrest drug sacubitril/valsartan offered by Swiss pharmaceutical firm Novartis and its companions in India is predicted fall as a lot as 60% with a number of Indian drugmakers gearing as much as launch its generic model......
View Details

Related News

• Gujarat FDCA attributes 45% of drug samples failing quality tests due to dissolution testing (25-09-2023)

---

• CDSCO says samples labelled as Cipla's and Sun Pharma's drugs failed in July could be spurious (25-09-2023)

---

• Govt in process of identifying additional regulatory interventions to stop Misuse of Antimicrobials (25-09-2023)

---

• Resistance to last-resort antibiotics Carbapenem growing in India: ICMR report (25-09-2023)

---

• 4 arrested with 375 bottles of Eskuf cough syrup worth Rs 4 lakh (25-09-2023)

---

• Ghaziabad: Fake Augmentin 625 Duo and Ultracet worth Rs 8 lakh seized, four arrested (24-09-2023)

---

• Police recovered 292 intoxicating capsules and 5760 pills in Ambala (24-09-2023)

---

• One Arrested by Cachar Police with 18,000 Yaba Tablets (24-09-2023)

---

• Indian-origin girl receives first rejection-free kidney from mother in UK (24-09-2023)

---

• 3D-printed medical devices gain ground (24-09-2023)

---